| Transcriptional factor PAX3 (PAX3) exerted its tumor suppressor function by inhibiting the activity of major signaling pathways and enhancing expression and activity of transcription factor forkhead box O3 protein (FOXO3a). | None |
| A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma. | sarcoma, |
| An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. | sarcoma, |
| PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. | sarcoma, |
| PAX3 might contribute to oncogenic characteristics of neuroblastoma cells by regulating a variety of crucial signalling pathways. | neuroblastoma, |
| Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma. | sarcoma, |
| Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. | sarcoma, |
| Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. | sarcoma, |
| The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. | None |
| cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. | None |
| Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. | None |
| Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. | None |
| Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. | None |
| Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. | None |
| Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. | None |
| PAX3-FKHR chimeric oncoprotein: hiding itself from immune detection?. | None |
| Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein. | None |
| The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes. | None |
| The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis. | None |
| Dissection of the functional interaction between p53 and the embryonic proto-oncoprotein PAX3. | None |